Signal Transduction in Allergic and Inflammatory Cells

Allergy and Allergic Diseases, Second Edition

Volumn 1, Issue , 2009, Pages 203-213

  Alam, Rafeul ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Activation of specific proteins through GTP binding; Epidermal growth factor (EGF) receptors; Immune cells and resident tissue cells participating in allergic diseases; NF B pathway and pathways for cell activation, survival, differentiation; Signal amplification mechanism and signaling through lipid raft; Signal transduction cellular process for environmental cues and cellular response; Signal transduction in allergic and inflammatory cells; Signal transduction in mast cells; Signaling integration and activation of MAPKs

Indexed keywords

EID: 79955977646     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300918.ch10     Document Type: Chapter

References (58)

1. Aaronson, D.S. & Horvath, C.M. (2002) A road map for those who don't know JAK-STAT. Science 296, 1653-5.
2. Adachi, T. & Alam, R. (1998) The mechanism of IL-5 signal transduction. Am J Physiol 275, C623-C633.
3. Alexander, W.S. & Hilton, D.J. (2004) The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 22, 503-29.
4. Barrow, A.D. & Trowsdale, J. (2006) You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur J Immunol 36, 1646-53.
5. Boggon, T.J. & Eck, M.J. (2004) Structure and regulation of Src family kinases. Oncogene 23, 7918-27.
6. Cantley, L.C. (2002) The phosphoinositide 3-kinase pathway. Science 296, 1655-7.
7. Cen, O., Gorska, M.M., Stafford, S.J., Sur, S. & Alam, R. (2003) Identification of UNC119 as a novel activator of SRC-type tyrosine kinases. J Biol Chem 278, 8837-45.
8. Chan, A.C., Kadlecek, T.A., Elder, M.E. et al. (1994) ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 264, 1599-601.
9. Colicelli, J. (2004) Human RAS superfamily proteins and related GTPases. Sci STKE 2004(250), RE13.
10. Daheshia, M., Friend, D.S., Grusby, M.J., Austen, K.F. & Katz, H.R. (2001) Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J Exp Med 194, 227-33.
11. Duan, W. & Wong, W.S. (2006) Targeting mitrogen-activated protein kinases for asthma. Curr Drug Targets 7, 691-8.
12. Dupuis, S., Dargemont, C., Fieschi, C. et al. (2001) Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293, 300-3.
13. Etienne-Manneville, S. & Hall, A. (2002) Rho GTPases in cell biology. Nature 420, 629-35.
14. Flaswinkel, H., Barner, M. & Reth, M. (1995) The tyrosine activation motif as a target of protein tyrosine kinases and SH2 domains. Semin Immunol 7, 21-7.
15. Gilfillan, A.M. & Tkaczyk, C. (2006) Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 6, 218-30.
16. Goldman, F.D., Ballas, Z.K., Schutte, B.C. et al. (1998) Defective expression of p56lck in an infant with severe combined immunodeficiency. J Clin Invest 102, 421-9.
17. Gorska, M.M., Stafford, S.J., Cen, O., Sur, S. & Alam, R. (2004) Unc119, a novel activator of Lck/Fyn, is essential for T cell activation. J Exp Med 199, 369-79.
18. Hubbard, K.B. & Hepler, J.R. (2006) Cell signalling diversity of the Gqalpha family of heterotrimeric G proteins. Cell Signal 18, 135-50.
19. Ilangumaran, S. & Rottapel, R. (2003) Regulation of cytokine receptor signaling by SOCS1. Immunol Rev 192, 196-211.
20. Inoue, H., Kato, R., Fukuyama, S. et al. (2005) Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness. J Exp Med 201, 73-82.
21. Isakov, N. (1997) ITIMs and ITAMs. The Yin and Yang of antigen and Fc receptor-linked signaling machinery. Immunol Res 16, 85-100.
22. Jordens, I., Marsman, M., Kuijl, C. & Neefjes, J. (2005) Rab proteins, connecting transport and vesicle fusion. Traffic 6, 1070-7.
23. Kagami, S., Nakajima, H., Kumano, K. et al. (2000) Both stat5a and stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue. Blood 95, 1370-7.
24. Kampen, G.T., Stafford, S, Adachi, T. et al. (2000) Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 95, 1911-17.
25. Kisseleva, T., Bhattacharya, S., Braunstein, J. & Schindler, C.W. (2002) Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285, 1-24.
26. Li, Q. & Verma, I.M. (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2, 725-34.
27. Lindquist, J.A., Simeoni, L. & Schraven, B. (2003) Transmembrane adapters: attractants for cytoplasmic effectors. Immunol Rev 191, 165-82.
28. Macchi, P., Villa, A., Giliani, S. et al. (1995) Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377, 65-8.
29. Martinez-Moczygemba, M. & Huston, D.P. (2001) Proteasomal regulation of betac signaling reveals a novel mechanism for cytokine receptor heterotypic desensitization. J Clin Invest 108, 1797-806.
30. Matsumoto, A., Masuhara, M., Mitsui, K. et al. (1997) CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89, 3148-54.
31. Minegishi, Y., Rohrer, J., Coustan-Smith, E. et al. (1999) An essential role for BLNK in human B cell development. Science 286, 1954-7.
32. Minegishi, Y., Saito, M., Morio, T. et al. (2006) Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25, 745-55.
33. Morra, M., Simarro-Grande, M., Martin, M. et al. (2001) Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients. J Biol Chem 276, 36809-16.
34. Murphy, K.M. & Reiner, S.L. (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2, 933-44.
35. Nadler, M.J., Matthews, S.A., Turner, H. & Kinet, J.P. (2000) Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function. Adv Immunol 76, 325-55.
36. O'Garra, A. & Robinson, D. (2004) Development and function of T helper 1 cells. Adv Immunol 83, 133-62.
37. Ono, M., Bolland, S., Tempst, P. & Ravetch, J.V. (1996) Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 383, 263-6.
38. Ortega, E., Schneider, H. & Pecht, I. (1991) Possible interactions between the Fcε receptor and a novel mast cell function-associated antigen. Int Immunol 3, 333-42.
39. Palacios, E.H. & Weiss, A. (2004) Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23, 7990-8000.
40. Paling, N.R. & Welham, M.J. (2002) Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling. Biochem J 368, 885-94.
41. Pazdrak, K., Schreiber, D., Forsythe, P., Justement, L. & Alam, R. (1995) The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J Exp Med 181, 1827-34.
42. Picard, C., Puel, A., Bonnet, M. et al. (2003) Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299, 2076-9.
43. Pierce, K.L., Premont, R.T. & Lefkowitz, R.J. (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3, 639-50.
44. Randazzo, P.A., Nie, Z., Miura, K. & Hsu, V.W. (2000) Molecular aspects of the cellular activities of ADP-ribosylation factors. Sci STKE 2000(59), RE1.
45. Rawlings, D.J., Saffran, D.C., Tsukada, S. et al. (1993) Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261, 358-61.
46. Rivera, J. (2005) NTAL/LAB and LAT: a balancing act in mast-cell activation and function. Trends Immunol 26, 119-22.
47. Rodgers, W., Farris, D. & Mishra, S. (2005) Merging complexes: properties of membrane raft assembly during lymphocyte signaling. Trends Immunol 26, 97-103.
48. Rodriguez-Viciana, P., Tetsu, O., Oda, K., Okada, J., Rauen, K. & McCormick, F. (2005) Cancer targets in the Ras pathway. Cold Spring Harb Symp Quant Biol 70, 461-7.
49. Roux, P.P. & Blenis, J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68, 320-44.
50. Shaw, R.J. & Cantley, L.C. (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441, 424-30.
51. Shlapatska, L.M., Mikhalap, S.V., Berdova, A.G. et al. (2001) CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J Immunol 166, 5480-7.
52. Torigoe, T., O'Connor, R., Santoli, D. & Reed, J.C. (1992) Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloidcommitted leukemic cell lines. Blood 80, 617-24.
53. Uehara, T., Blery, M., Kang, D.W. et al. (2001) Inhibition of IgEmediated mast cell activation by the paired Ig-like receptor PIR-B. J Clin Invest 108, 1041-50.
54. van der Bruggen, T., Caldenhoven, E., Kanters, D. et al. (1995) Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha. Blood 85, 1442-8.
55. Wonerow, P. & Watson, S.P. (2001) The transmembrane adapter LAT plays a central role in immune receptor signaling. Oncogene 20, 297-305.
56. Yang, X.J. (2005) Multisite protein modification and intramolecular signaling. Oncogene 24, 1653-62.
57. Zhang, X., Gureasko, J., Shen, K., Cole, P.A. & Kuriyan, J. (2006) An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125, 1137-49.
58. Zonana, J., Elder, M.E., Schneider, L.C. et al. (2000) A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 67, 1555-62.